HIV Treatment Guidelines
Coverage of the 14th European AIDS Conference
- Details
- Category: HIV Treatment
- Published on Sunday, 20 October 2013 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 14th European AIDS Conference, sponsored by the European AIDS Clinical Society (EACS), October 16-19, 2013, in Brussels.
Conference highlights include antiretroviral therapy strategies and new HIV drugs, new treatment for hepatitis C, biomedical HIV prevention, HIV cure research, and the epidemic in Eastern Europe.
10/20/13
EACS 2013: New European Treatment Guidelines Strike Balance Between Individual Choice and Public Health
- Details
- Category: HIV Treatment Guidelines
- Published on Friday, 18 October 2013 00:00
- Written by Gus Cairns
A new edition of the European AIDS Clinical Society (EACS) guidelines for the treatment of HIV, HIV/hepatitis C coinfection, and HIV with other comorbidities were published in advance of the 14th European AIDS Conference currently taking place in Brussels and were presented and discussed at a special session and press conference Friday.
IAS 2013: Reduced Efavirenz Dose Suppresses HIV as Well as Standard Dose
- Details
- Category: HIV Treatment
- Published on Wednesday, 03 July 2013 00:00
- Written by Liz Highleyman
Lowering the dosage of efavirenz (Sustiva) from 600 to 400 mg in an antiretroviral regimen did not compromise efficacy, and has the potential to substantially reduce treatment cost, according to data from the ENCORE1 study presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
IAS 2013: Study Supports WHO Second-line HIV Treatment Guidelines for Resource-limited Countries
- Details
- Category: HIV Treatment
- Published on Wednesday, 03 July 2013 00:00
- Written by Liz Highleyman
A second-line regimen consisting of a protease inhibitor (PI) plus 2 nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) led to good outcomes for people with HIV in Africa after initial regimen failure, according to data from the EARNEST study presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur. A NRTI-sparing regimen with raltegravir did not work significantly better, and PImonotherapy was inferior.
IAS 2013: WHO Guidelines Call for Earlier HIV Treatment [VIDEO]
- Details
- Category: HIV Treatment
- Published on Tuesday, 02 July 2013 00:00
- Written by Gregory Fowler
The World Health Organization (WHO) issued new global guidelines for antiretroviral therapy on June 30 at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur.
More Articles...
- IAS 2013: New WHO Guidelines on HIV Treatment for Children Require Earlier Diagnosis
- IAS 2013: WHO Issues New HIV Recommendations Calling For Earlier Antiretroviral Initiation
- Updated Opportunistic Infection Guidelines Add Info on IRIS, Hepatitis, Drug Interactions
- Updated HIV Treatment Guidelines Include Stronger Recommendation for Acute Infection